Terms: = Brain cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2
9 results:
1. Modifiable risk factors for glioblastoma: a systematic review and meta-analysis.
Yoshikawa MH; Rabelo NN; Telles JPM; Figueiredo EG
Neurosurg Rev; 2023 Jun; 46(1):143. PubMed ID: 37340151
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract] [Full Text] [Related]
3. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
Voermans NC; van der Bilt RC; IJspeert J; Hogrel JY; Jeanpierre M; Behin A; Laforet P; Stojkovic T; van Engelen BG; Padberg GW; Sacconi S; Lemmers RJLF; van der Maarel SM; Eymard B; Bassez G
J Neurol; 2019 Dec; 266(12):2987-2996. PubMed ID: 31471688
[TBL] [Abstract] [Full Text] [Related]
4. Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients.
Duma MN; Oszfolk NI; Boeckh-Behrens T; Oechsner M; Zimmer C; Meyer B; Pfluger PT; Combs SE
Radiat Oncol; 2019 Jun; 14(1):97. PubMed ID: 31174561
[TBL] [Abstract] [Full Text] [Related]
5. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
Barami K; Lyon L; Conell C
World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
[TBL] [Abstract] [Full Text] [Related]
6. Non-canonical Hedgehog/AMPK-Mediated Control of Polyamine Metabolism Supports Neuronal and Medulloblastoma Cell Growth.
D'Amico D; Antonucci L; Di Magno L; Coni S; Sdruscia G; Macone A; Miele E; Infante P; Di Marcotullio L; De Smaele E; Ferretti E; Ciapponi L; Giangaspero F; Yates JR; Agostinelli E; Cardinali B; Screpanti I; Gulino A; Canettieri G
Dev Cell; 2015 Oct; 35(1):21-35. PubMed ID: 26460945
[TBL] [Abstract] [Full Text] [Related]
7. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.
Bachinski LL; Baggerly KA; Neubauer VL; Nixon TJ; Raheem O; Sirito M; Unruh AK; Zhang J; Nagarajan L; Timchenko LT; Bassez G; Eymard B; Gamez J; Ashizawa T; Mendell JR; Udd B; Krahe R
Neuromuscul Disord; 2014 Mar; 24(3):227-40. PubMed ID: 24332166
[TBL] [Abstract] [Full Text] [Related]
8. Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.
Welch MR; Grommes C
CNS Oncol; 2013 May; 2(3):237-46. PubMed ID: 25054464
[TBL] [Abstract] [Full Text] [Related]
9. Myotonic dystrophy: from bench to bedside.
Johnson NE; Heatwole CR
Semin Neurol; 2012 Jul; 32(3):246-54. PubMed ID: 23117949
[TBL] [Abstract] [Full Text] [Related]
